|
PURB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.624400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.464100E-03 |
| Normal-vs-Stage2 |
2.425800E-01 |
| Normal-vs-Stage3 |
9.193000E-01 |
| Normal-vs-Stage4 |
3.715200E-01 |
| Stage1-vs-Stage2 |
9.690600E-01 |
| Stage1-vs-Stage3 |
1.978620E-01 |
| Stage1-vs-Stage4 |
9.495200E-01 |
| Stage2-vs-Stage3 |
3.452800E-01 |
| Stage2-vs-Stage4 |
9.381400E-01 |
| Stage3-vs-Stage4 |
3.926400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.884650E-03 |
| Normal-vs-AfricanAmerican |
2.803600E-02 |
| Normal-vs-Asian |
5.059900E-02 |
| Caucasian-vs-AfricanAmerican |
9.807200E-01 |
| Caucasian-vs-Asian |
1.354580E-01 |
| AfricanAmerican-vs-Asian |
1.048200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.522260E-03 |
| Normal-vs-Female |
2.036400E-02 |
| Male-vs-Female |
9.688800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.095200E-01 |
| Normal-vs-Extreme_Weight |
6.282200E-02 |
| Normal-vs-Obese |
4.043300E-03 |
| Normal-vs-Extreme_Obese |
4.571000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.066000E-01 |
| Normal_Weight-vs-Obese |
2.498200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.076800E-01 |
| Extreme_Weight-vs-Obese |
5.560400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.541200E-01 |
| Obese-vs-Extreme_Obese |
5.538600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.121420E-01 |
| Normal-vs-Age(41-60Yrs) |
5.79229999999598E-05 |
| Normal-vs-Age(61-80Yrs) |
1.200410E-01 |
| Normal-vs-Age(81-100Yrs) |
8.069200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.916580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.610200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.256200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.028020E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.391600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.903000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.84579999962642E-08 |
| Normal-VS-Type2 PRCC |
6.533600E-02 |
| Normal-VS-KIRP CIMP |
8.801000E-01 |
| Normal-VS-Unclassified PRCC |
1.042220E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.26970000069448E-08 |
| Type1 PRCC-VS-KIRP CIMP |
8.823700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.157600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.759600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.725000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.385600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.848400E-01 |
| Normal-vs-N1 |
1.332850E-01 |
| Normal-vs-N2 |
1.259980E-01 |
| N0-vs-N1 |
5.669700E-02 |
| N0-vs-N2 |
5.966800E-01 |
| N1-vs-N2 |
1.130200E-02 |
|
|
